Perspectives on Adherence and Persistence With Oral Medications for Cancer Treatment
- 1 January 2011
- journal article
- perspective
- Published by American Society of Clinical Oncology (ASCO) in Journal of Oncology Practice
- Vol. 7 (1), 65-67
- https://doi.org/10.1200/jop.2010.000076
Abstract
Ensuring persistence, continuing treatment for the prescribed duration, and adherence—taking medication as prescribed—have been challenges for management of patients with oral cancer and for health care cost containment in real-world settings.Keywords
This publication has 30 references indexed in Scilit:
- Early Discontinuation and Nonadherence to Adjuvant Hormonal Therapy in a Cohort of 8,769 Early-Stage Breast Cancer PatientsJournal of Clinical Oncology, 2010
- Adherence and Persistence With Oral Adjuvant Chemotherapy in Older Women With Early-Stage Breast Cancer in CALGB 49907: Adherence Companion Study 60104Journal of Clinical Oncology, 2010
- Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancerAnnals of Oncology, 2009
- Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancerBritish Journal of Cancer, 2008
- Adherence to Initial Adjuvant Anastrozole Therapy Among Women With Early-Stage Breast CancerJournal of Clinical Oncology, 2008
- Medication Compliance and Persistence: Terminology and DefinitionsValue in Health, 2008
- Early discontinuation of tamoxifenCancer, 2007
- Adherence to tamoxifen over the five-year courseBreast Cancer Research and Treatment, 2006
- Adherence to MedicationThe New England Journal of Medicine, 2005
- Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid LeukemiaThe New England Journal of Medicine, 2003